Another case of PML hits the MS drug Tysabri

PML is a rare demylinating disease that occurs in 6 per 10 million patients. This is the third case that is associated with Tysabri. Investors are not happy.

Similar Posts:

• Lose your fingerprints from chemotherapy
• A 10-year old girl with breast cancer, how much media coverage should she receive?
• Situs inversus, and the difficulty of operating on patients with reversed anatomy

Tagged as: patient